Kenneth Hoberman Tg Therapeutics, Inc. (TGTX) insider trading activity

Kenneth Hoberman is Director of TG THERAPEUTICS, INC.. Currently has a direct ownership of 279,653 shares of TGTX, which is worth approximately $10.1 Million. The most recent transaction as insider was on Jun 12, 2025, when has been sold 14,718 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 280K

5.56% 3M change

5.56% 12M change

Total Value Held $10.1 Million

Kenneth Hoberman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2025	BUY Grant, award, or other acquisition	-	14,718 Added 5.0%	279,653 Common Stock
Jun 19 2024	BUY Grant, award, or other acquisition	-	22,250 Added 7.75%	264,935 Common Stock
Sep 28 2023	BUY Grant, award, or other acquisition	-	20,000 Added 7.61%	242,685 Common Stock
Jul 20 2022	BUY Grant, award, or other acquisition	-	43,732 Added 16.41%	222,685 Common Stock
Jun 18 2021	BUY Grant, award, or other acquisition	-	20,000 Added 10.05%	178,953 Common Stock

Also insider at

NVCT

Nuvectis Pharma, Inc. Healthcare

Director